Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Ozurdex as Monotherapy for Treatment of Non-infectious Intermediate, Posterior, or Panuveitis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05101928
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:44.850977+00:00
Published At
2025-03-12T00:00:00+00:00
Record Updated At
2025-03-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Uveitis, Posterior", "Uveitis, Intermediate", "Panuveitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-12"
protocolSection.identificationModule.nctId
"NCT05101928"
protocolSection.identificationModule.officialTitle
"Ozurdex as Monotherapy for Treatment of Non-infectious Intermediate, Posterior, or Panuveitis"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Uveitis, Posterior (protocolSection.conditionsModule.conditions)
  • Uveitis, Intermediate (protocolSection.conditionsModule.conditions)
  • Panuveitis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.